Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

NRXP NRX Pharmaceuticals Inc

2,10

0,03 (1,45%)

29 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Biotech Soars On Large Investment Announcement Into Its Subsidiary

A Delaware-based biotech company turned heads on Tuesday after it was announced that it has invested $27 million in its subsidiary Hope Therapeutics to fund clinic acquisitions...

To read the full story on AllPennyStocks.com, click here.

NRX Pharmaceuticals (NASDAQ:NRXP)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more NRX Pharmaceuticals Charts.

NRX Pharmaceuticals (NASDAQ:NRXP)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more NRX Pharmaceuticals Charts.

News NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
Montag 21 April 2025 (1 Woche vor) • PR Newswire (US)

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
Donnerstag 3 April 2025 (4 Wochen vor) • PR Newswire (US)

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics
Montag 31 März 2025 (4 Wochen vor) • PR Newswire (US)

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Letter of Intent with Neurospa TMS Holdings, LLC for Expansion of its Planned International Network of Interventional Psychiatry Clinics
Montag 24 März 2025 (1 Monat vor) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Montag 17 März 2025 (1 Monat vor) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 17, 2025
Mittwoch 12 März 2025 (2 Monate vor) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025
Donnerstag 6 Februar 2025 (3 Monate vor) • PR Newswire (US)

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
Montag 3 Februar 2025 (3 Monate vor) • PR Newswire (US)

Biotech Soars On Large Investment Announcement Into Its Subsidiary
Dienstag 28 Januar 2025 (3 Monate vor) • AllPennyStocks.com

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
Dienstag 28 Januar 2025 (3 Monate vor) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt
Dienstag 28 Januar 2025 (3 Monate vor) • PR Newswire (US)

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
Dienstag 21 Januar 2025 (3 Monate vor) • PR Newswire (US)

Weitere NRX Pharmaceuticals Inc News-Artikel

Deutsche Lufthansa

Euro vs US Dollar

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen